Home » Topics » BioWorld Science

BioWorld Science
RSS

B cells help T cells succeed during checkpoint blockade

Jan. 20, 2020

Roche discloses new EGFR mutant inhibitors

Jan. 20, 2020

Suzhou Mednes Pharma Tech patents hedgehog signaling inhibitors

Jan. 20, 2020

ASIT Biotech publishes phase III data for gp-ASIT+ grass allergen peptide immunotherapy

Jan. 20, 2020

OXi-4503 in combination with ARA-C shows safety and early clinical efficacy in AML

Jan. 20, 2020

Novel muraminomicin derivatives with potent activity in MRSA infection models

Jan. 20, 2020

Sanofi initiates phase III study of SAR-408701 in CEACAM5-positive metastatic nonsquamous NSCLC

Jan. 20, 2020

Enrollment ongoing in phase I/II study of oral BDTX-189 in advanced solid tumors

Jan. 20, 2020

Clene opens phase II study of CNM-Au8 in ALS

Jan. 17, 2020

Amgen studies AMG-199 in patients with MUC17-positive gastric and GEJ cancer

Jan. 17, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...